Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 2/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | HTR6 | P50406 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30513711 | 1.00 | DAO (0.41) | DAOTAAR1IDO1HRH3HTR2C | |
| SCHEMBL12814982 | 0.85 | DAO (0.44) | DAOTAAR1IDO1HRH3HTR2C | |
| SCHEMBL30513712 | 0.83 | CALM1 (0.35) | MEN1KMT2A | |
| SCHEMBL21494763 | 0.83 | CALM1 (0.35) | MEN1KMT2A | |
| SCHEMBL9763617 | 0.81 | DAO (0.46) | DAOTAAR1IDO1HRH3HTR2C | |
| SCHEMBL21494670 | 0.80 | IDO1 (0.34) | DAOTAAR1IDO1HRH3HTR2C | |
| SCHEMBL3923571 | 0.79 | CALM1 (0.42) | DAOTAAR1POLB | |
| SCHEMBL8294253 | 0.79 | BCHE (0.40) | TAAR1IDO1HRH3 | |
| SCHEMBL17614136 | 0.77 | MAOB (0.46) | HRH3HTR6MAOBPOLBKMT2A | |
| SCHEMBL21494727 | 0.72 | DAO (0.45) | DAOTAAR1IDO1HRH3HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138121-A1 | SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS | CHEVRON U S A INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4601788-A1 | CATALYST SYSTEM AND METHOD FOR CATALYTICALLY DEHYDRATING A HYDROGEN CARRIER MATERIAL, REACTOR ARRANGEMENT WITH SUCH A CATALYST SYSTEM AND METHOD FOR PRODUCING SUCH A CATALYST SYSTEM | HYDROGENIOUS LOHC TECHNOLOGIES GMBH (DE) | 2025-08-20 | — | — | EP | disclosed |
| US-12269018-B2 | Platinum-sulfur-based shell catalyst, production and use thereof in the dehydrogenation of hydrocarbons | CLARIANT INTERNATIONAL LTD (CH) | 2025-04-08 | — | — | US | disclosed |
| US-20250065311-A1 | SULFIDATED NOBLE METAL ON METAL DOPED SUPPORT AS A HYDROGENATION AND DEHYDROGENATION CATALYST | CHEVRON USA INC (US) | 2025-02-27 | — | — | US | disclosed |
| WO-2024078958-A1 | CATALYST SYSTEM AND METHOD FOR CATALYTICALLY DEHYDRATING A HYDROGEN CARRIER MATERIAL, REACTOR ARRANGEMENT WITH SUCH A CATALYST SYSTEM AND METHOD FOR PRODUCING SUCH A CATALYST SYSTEM | HYDROGENIOUS LOHC TECHNOLOGIES GMBH (DE) | 2024-04-18 | — | — | WO | disclosed |
| CN-111989156-B | Shell catalyst based on platinum-sulphur, production and use in hydrocarbon dehydrogenation | 科莱恩国际有限公司 | 2023-08-11 | — | — | CN | disclosed |
| US-20210077984-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | CLARIANT INTERNATIONAL LTD (CH) | 2021-03-18 | — | — | US | disclosed |
| EP-3781307-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | Clariant International Ltd (CH) | 2021-02-24 | — | — | EP | disclosed |
| CN-111989156-A | Platinum-sulfur based shell catalysts, their production and use in the dehydrogenation of hydrocarbons | 科莱恩国际有限公司 | 2020-11-24 | — | — | CN | disclosed |
| WO-2019201706-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | CLARIANT INTERNATIONAL LTD (CH) | 2019-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138121-A1 | SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS | NUDC, SOD1, TIMM10 | DAO 3352/4885TAAR1 4199/4885IDO1 858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.